2016
DOI: 10.1080/09602011.2016.1189341
|View full text |Cite
|
Sign up to set email alerts
|

Personalised treatment for cognitive dysfunction in individuals with schizophrenia spectrum disorders

Abstract: Cognitive deficits are a well-recognized issue for individuals diagnosed with schizophrenia spectrum disorders. Despite positive group findings for the use of cognitive remediation (CR) interventions, there are substantial individual differences in response to treatment. In addition, the aggregate CR literature reports low moderate effect sizes for cognitive and functional outcomes. Based on personalized medicine theory, this paper uses extant CR literature to examine the individual characteristics determined … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
30
1

Year Published

2017
2017
2024
2024

Publication Types

Select...
3
3
1

Relationship

0
7

Authors

Journals

citations
Cited by 36 publications
(31 citation statements)
references
References 64 publications
0
30
1
Order By: Relevance
“…However, group-level analyses cannot take into account the substantial individual neuroanatomical heterogeneity that occurs at the individual level in SCZ (28). The goal of precision-medicine is to select and adapt therapeutic approaches based on each patient's individual neural and clinical characteristics (29,30). In order to take into account individual neuroanatomical heterogeneity at baseline and reliably validate the origin of the predictive information, we replaced patients' GAF scores at post ABCT with their baseline scores and repeated the sMRI GM analysis.…”
Section: Discussionmentioning
confidence: 99%
“…However, group-level analyses cannot take into account the substantial individual neuroanatomical heterogeneity that occurs at the individual level in SCZ (28). The goal of precision-medicine is to select and adapt therapeutic approaches based on each patient's individual neural and clinical characteristics (29,30). In order to take into account individual neuroanatomical heterogeneity at baseline and reliably validate the origin of the predictive information, we replaced patients' GAF scores at post ABCT with their baseline scores and repeated the sMRI GM analysis.…”
Section: Discussionmentioning
confidence: 99%
“…People with schizophrenia present with heterogeneous cognitive profiles, with some patients showing impairments in several areas and others presenting with only mild deficits [ 1 ]. In order to enhance CRT efficacy, it is thus important to determine the variables underlying each individual's deficits and tailor the CRT to suit these specific deficits [ 73 ]. All patients start CRT with their own strengths and weaknesses, and it is increasingly recognized that better outcome is achieved when the treatment is personalized for a given patient based on his cognitive profile [ 37 , 73 , 74 ].…”
Section: Discussionmentioning
confidence: 99%
“…In order to enhance CRT efficacy, it is thus important to determine the variables underlying each individual's deficits and tailor the CRT to suit these specific deficits [ 73 ]. All patients start CRT with their own strengths and weaknesses, and it is increasingly recognized that better outcome is achieved when the treatment is personalized for a given patient based on his cognitive profile [ 37 , 73 , 74 ]. In fact, patients' cognitive profiles before the start of CRT has been reported as an important factor for treatment outcome in several studies [ 73 , 75 77 ].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations